WuXi Biologics is preparing for a Hong Kong flotation. Innovation friendly policies have boosted the mainland drug market. But foreign investors lack ways to bet on this big part of China's new economy. They should be keen to inject money into WuXi.
Please read our new Privacy Statement before continuing.